Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neuralstem Inc (NASDAQ:CUR)

0.60
Delayed Data
As of Apr 29
 +0.01 / +1.69%
Today’s Change
0.52
Today|||52-Week Range
2.37
-41.75%
Year-to-Date
No recent news for Neuralstem Inc.

Today’s Trading

Previous close0.59
Today’s open0.58
Day’s range0.55 - 0.62
Volume151,463
Average volume (3 months)238,801
Market cap$54.3M
Dividend yield--
Data as of 3:59pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+11.54%
Earnings growth (this year)+4.35%
Earnings growth (next 5 years)--
Revenue growth (last year)-44.69%
P/E ratioNM
Price/Sales8,984.64
Price/Book10.93

Competitors

 Today’s
change
Today’s
% change
FATEFate Therapeutics In...-0.06-3.06%
VBIVVBI Vaccines Inc-0.04-1.78%
VSTMVerastem Inc-0.03-1.79%
CANFCan Fite Biopharma L...-0.05-1.73%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 4, 2016
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$10.4K
Annual profit (last year)-$20.9M
Net profit margin-200,671.03%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Scientific Officer
Karl Y. Johe
President, Chief Executive Officer &
Director
Richard J. Daly
Corporate headquarters
Germantown, Maryland

Forecasts

Partner Offers

Search for Jobs